Literature DB >> 15713442

Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta.

Noriko Ejiri1, Kei-ichi Katayama, Kunio Doi.   

Abstract

Cytochrome P450 (CYP) isozymes are important in metabolizing xenobiotics. They are found in extrahepatic tissues such as placenta as well as liver. Previously, we reported that CYP3A1 was detected in the cytoplasm of giant cells in the trophoblastic region of placenta of rats through pregnancy. In this study, we examined the changes in the expression of CYP proteins in the pregnant rat and fetal livers and placenta after treatment with phenobarbital (PB), one of the antiepileptic drugs which is well known to induce several phase I and phase II drug metabolizing enzymes in the liver. Namely, F344 pregnant rats were treated with PB (80 mg/kg, i.p.) from 13 days of gestation (DG) to 16 DG. All animals were sacrificed on 17 DG, and Western blot analysis and immunohistochemical staining on nine CYP proteins (CYP1A1, CYP2B1, CYP2C6, CYP2C12, CYP2D1, CYP2D4, CYP2E1, CYP3A1, and CYP4A1) and histological examination were done in the dam's liver, placenta, and the fetal liver. Western blot analysis revealed that CYP3A1 protein was significantly induced, CYP2B1 protein was detected, and CYP2D1 protein was significantly decreased in the dam's liver after PB-treatment. In placenta, only CYP3A1 was detected with no difference between control and PB-treated animals. The results of immunohistochemical staining corresponded closely to those of Western blot analysis in the dam's liver and placenta. In the fetal liver, CYP3A1 and CYP2C6 proteins were significantly induced after the PB-treatment, but their immunostainability was not prominent. The present results are considered useful as a basis for further investigation of drug metabolism in pregnant animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713442     DOI: 10.1016/j.yexmp.2004.07.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  5 in total

1.  Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

Authors:  Natasha P Clayton; Katsuhiko Yoshizawa; Grace E Kissling; Leo T Burka; Po-Chuen Chan; Abraham Nyska
Journal:  Exp Toxicol Pathol       Date:  2006-10-23

2.  Drug Interactions at the Human Placenta: What is the Evidence?

Authors:  Miriam Rubinchik-Stern; Sara Eyal
Journal:  Front Pharmacol       Date:  2012-07-09       Impact factor: 5.810

Review 3.  Morphology and physiology of rat placenta for toxicological evaluation.

Authors:  Satoshi Furukawa; Naho Tsuji; Akihiko Sugiyama
Journal:  J Toxicol Pathol       Date:  2018-10-15       Impact factor: 1.628

4.  Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.

Authors:  Michela Cantiello; Monica Carletti; Mery Giantin; Giulia Gardini; Francesca Capolongo; Paolo Cascio; Marianna Pauletto; Flavia Girolami; Mauro Dacasto; Carlo Nebbia
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

5.  Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.

Authors:  Juan C Velasquez; Nick Goeden; Skyla M Herod; Alexandre Bonnin
Journal:  ACS Chem Neurosci       Date:  2016-01-30       Impact factor: 4.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.